Epigenetic Modifications and Therapy in Chronic Obstructive Pulmonary Disease (COPD): An Update Review.


Journal

COPD
ISSN: 1541-2563
Titre abrégé: COPD
Pays: England
ID NLM: 101211769

Informations de publication

Date de publication:
06 2020
Historique:
pubmed: 20 6 2020
medline: 9 9 2021
entrez: 20 6 2020
Statut: ppublish

Résumé

Chronic obstructive pulmonary disease (COPD) that is one of the most prevalent chronic adult diseases and the third leading cause of fatality until 2020. Elastase/anti-elastase hypothesis, chronic inflammation, apoptosis, oxidant-antioxidant balance and infective repair cause pathogenesis of COPD are among the factors at play. Epigenetic changes are post-translational modifications in histone proteins and DNA such as methylation and acetylation as well as dysregulation of miRNAs expression. In this update review, we have examined recent studies on the upregulation or downregulation of methylation in different genes associated with COPD. Dysregulation of HDAC activity which is caused by some factors and miRNAs plays a key role in the suppression and reduction of COPD development. Also, some therapeutic approaches are proposed against COPD by targeting HDAC2 and miRNAs, which have therapeutic effects.

Identifiants

pubmed: 32558592
doi: 10.1080/15412555.2020.1780576
doi:

Substances chimiques

Histone Deacetylase Inhibitors 0
MicroRNAs 0
Histone Deacetylase 2 EC 3.5.1.98

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

333-342

Auteurs

Lingzhi Zhang (L)

Department of Emergency Medicine, Shengjing Hospital of China Medical University, Shenyang, China.

Hamed Valizadeh (H)

Department of Internal Medicine and Pulmonology, Faculty of Medicine, Urmia University of Medical Sciences, Urmia, Iran.
Tuberculosis and Lung Disease Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.

Iraj Alipourfard (I)

Faculty of Life Sciences, Center of pharmaceutical sciences, University of Vienna, Vienna, Austria.
Faculty of Sciences, School of Pharmacy, University of Rome Tor Vergata, Roma, Italy.

Ramtin Bidares (R)

Department of Experimental Medicine, Sapienza University, Rome, Italy.

Leili Aghebati-Maleki (L)

Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.

Majid Ahmadi (M)

Stem Cell Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH